Evaluation of Oral Health in Early Stages of Chronic Kidney Disease.
8 affiliations
- 1Department of Oral Surgery, Centre Hospitalier Universitaire de Bordeaux, F-33076 Bordeaux, France.
- 2Laboratoire de Bioingénierie Tissulaire, Institut National de la Santé et de la Recherche Médicale, University of Bordeaux, U1026, F-33000 Bordeaux, France.
- 3Bordeaux Sciences Agro, Bordeaux INP, INRAE, University of Bordeaux, UMR 1366, OENO, ISVV, F-33140 Villenave d'Ornon, France.
- 4Pôle de Médecine et Chirurgie Bucco-Dentaire, Centre Hospitalier Universitaire de Bordeaux, F-33076 Bordeaux, France.
- 5Bordeaux Population Health, Institut National de la Santé et de la Recherche Médicale, University of Bordeaux, U1219, F-33000 Bordeaux, France.
- 6Clinical Epidemiology Unit (USMR), Pôle de Santé Publique, Centre Hospitalier Universitaire de Bordeaux, F-33076 Bordeaux, France.
- 7Department of Clinical Research and Innovation, Centre Hospitalier Universitaire de Bordeaux, F-33076 Bordeaux, France.
- 8Unit of Nephrology, Service de Néphrologie, Dialyse, Transplantation et Aphérèses, Centre Hospitalier Universitaire de Bordeaux, F-33076 Bordeaux, France.
Abstract
Background/Objectives: Oral health may be affected by chronic kidney disease (CKD) through mechanisms including uremic toxin accumulation, immune dysregulation, and treatment-related factors, although these relationships remain poorly understood. This study aimed to describe oral health according to CKD stages (2-5) and to explore its association with disease progression, as well as one-year changes in oral, renal, and inflammatory parameters and oral health-related quality of life. Methods: The NephroDent study is a prospective cohort study including patients with non-dialysis CKD stages 2 to 5. Oral, clinical, and biological parameters and quality of life were assessed at baseline and after one year. Baseline characteristics were compared across CKD stages, and changes were analyzed according to self-reported dental care. Results: Eighty-seven patients were included. Oral health impairment was observed across all CKD stages, including stages 2 and 3, with substantial periodontal treatment needs and periodontal pockets ≥ 6 mm. Dental and periodontal parameters varied across stages, with some indicators showing numerically poorer values in stages 4-5, but no significant differences were observed between CKD stages. Over one year, changes in oral health indices, renal function (eGFR), inflammatory markers, and quality of life did not differ significantly according to dental care. Conclusions: Oral health impairment was observed across all CKD stages, including early disease, despite preserved quality of life. No significant short-term association was found between dental care and changes in oral or systemic parameters. Further studies are needed to clarify the role of oral health in CKD progression.
Related
- Reproducibility and Leakage-Controlled Evaluation of Machine-Learning Models for Chronic Kidney Disease Classification
- Evaluation of γδ T cells in autosomal dominant polycystic kidney disease
- Cognitive disorders in patients with chronic kidney disease: Approaches to prevention and treatment
- Platelet-derived microparticles induce CD8+ T cell senescence in chronic kidney disease via the transfer of microRNA-550a-5p
- The steps of constructing and validating an algorithm to identify chronic kidney disease patients in medical administrative databases
BibTeX
@article{catros2026evaluation,
title = {{Evaluation of Oral Health in Early Stages of Chronic Kidney Disease.}},
author = {Sylvain Catros and Johan Samot and Virginie Chuy and Eléonore Tron and Fideline Collin and Antoine Bénard and Claire Rigothier},
journal = {Dentistry journal},
year = {2026},
month = oct,
doi = {10.3390/dj14100646},
url = {https://europepmc.org/article/MED/42930412},
note = {CC BY},
}
RIS
TY - JOUR
TI - Evaluation of Oral Health in Early Stages of Chronic Kidney Disease.
AU - Sylvain Catros
AU - Johan Samot
AU - Virginie Chuy
AU - Eléonore Tron
AU - Fideline Collin
AU - Antoine Bénard
AU - Claire Rigothier
PY - 2026
DA - 2026/10/07
JO - Dentistry journal
DO - 10.3390/dj14100646
UR - https://europepmc.org/article/MED/42930412
AB - Background/Objectives: Oral health may be affected by chronic kidney disease (CKD) through mechanisms including uremic toxin accumulation, immune dysregulation, and treatment-related factors, although these relationships remain poorly understood. This study aimed to describe oral health according to CKD stages (2-5) and to explore its association with disease progression, as well as one-year changes in oral, renal, and inflammatory parameters and oral health-related quality of life. Methods: The NephroDent study is a prospective cohort study including patients with non-dialysis CKD stages 2 to 5. Oral, clinical, and biological parameters and quality of life were assessed at baseline and after one year. Baseline characteristics were compared across CKD stages, and changes were analyzed according to self-reported dental care. Results: Eighty-seven patients were included. Oral health impairment was observed across all CKD stages, including stages 2 and 3, with substantial periodontal treatment needs and periodontal pockets ≥ 6 mm. Dental and periodontal parameters varied across stages, with some indicators showing numerically poorer values in stages 4-5, but no significant differences were observed between CKD stages. Over one year, changes in oral health indices, renal function (eGFR), inflammatory markers, and quality of life did not differ significantly according to dental care. Conclusions: Oral health impairment was observed across all CKD stages, including early disease, despite preserved quality of life. No significant short-term association was found between dental care and changes in oral or systemic parameters. Further studies are needed to clarify the role of oral health in CKD progression.
SN - 2304-6767
ER -